Physician profile
Mark Stephen Chaney
NPI 1932294063
$3,634.23
in general payments reported to CMS, 2019-2025
7 companies · $159 in 2025
The $159 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $500 · 2021: $1,833 · 2022: $191 · 2023: $286 · 2024: $297 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592 · Education: $100 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $49.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $592.10 |
| Education | $100.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $49.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,640.80 | 2019-2022 | |
| Zimvie INC. | $643.58 | 2022-2025 | |
| Straumann USA LLC | $198.18 | 2023-2025 | |
| Henry Schein, INC. | $79.02 | 2019 | |
| Peter Brasseler Holdings, LLC | $37.08 | 2021 | |
| Solventum Corporation | $21.49 | 2024 | 3m Filtek |
| Ultradent Products INC | $14.08 | 2023 | Opalescence |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Chaney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.